Aprea Therapeutics APRE
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 2.75 | 108.27 | -0.64 | -4,097 | -4 | |
| 2024Q2 | 4.07 | 110.86 | -0.57 | -3,847 | -3 | |
| 2024Q1 | 6.69 | 112.10 | -0.67 | -3,150 | -3 | |
| 2023Q4 | 4.70 | 106.74 | -0.92 | -3,675 | -3 | |
| 2023Q3 | 4.17 | 109.92 | -0.85 | -3,523 | -3 | |
| 2023Q2 | 3.15 | 112.06 | -0.84 | -3,652 | -3 | |
| 2023Q1 | 4.44 | 105.55 | -1.34 | -4,623 | -4 | |
| 2022Q4 | 6.62 | 91.73 | 15.34 | -2,652 | -2 | |
| 2022Q3 | 13.00 | 99.29 | 11.98 | -4,200 | -4 | |
| 2022Q2 | 15.00 | 100.16 | -88.06 | -98,466 | -98 | |
| 2022Q1 | 37.20 | 101.71 | -7.25 | -8,075 | -8 | |
| 2021Q4 | 57.40 | 100.93 | -7.08 | -7,829 | -8 | |
| 2021Q3 | 102.20 | 99.77 | -9.00 | -9,430 | -9 | |
| 2021Q2 | 97.60 | 97.53 | -9.60 | -9,998 | -10 | |
| 2021Q1 | 102.00 | 105.40 | -9.20 | -10,190 | -10 | |
| 2020Q4 | 98.40 | 92.38 | -14.61 | -14,223 | -15 | |
| 2020Q3 | 481.20 | 99.39 | -11.60 | -12,234 | -12 | |
| 2020Q2 | 775.60 | 88.46 | -15.40 | -14,481 | -16 | |
| 2020Q1 | 695.20 | 123.36 | -9.00 | -11,873 | -9 | |
| 2019Q4 | 917.80 | 90.46 | 161.00 | -11,980 | -13 |